Evidence map›Paper›PMID 29706949›Full record

ArticleFrontiers in immunology2018

A Shared Epitope of Collagen Type XI and Type II Is Recognized by Pathogenic Antibodies in Mice and Humans with Arthritis.

Dongmei Tong, Erik Lönnblom, Anthony C Y Yau, Kutty Selva Nandakumar, Bibo Liang, Changrong Ge, Johan Viljanen, Lei Li, Mirela Bãlan, Lars Klareskog and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Dongmei TongDepartment of Medical Biochemistry and Biophysics, Section for Medical Inflammation Research, Karolinska Institute, Stockholm, Sweden.
Erik LönnblomDepartment of Medical Biochemistry and Biophysics, Section for Medical Inflammation Research, Karolinska Institute, Stockholm, Sweden.
Anthony C Y YauDepartment of Medical Biochemistry and Biophysics, Section for Medical Inflammation Research, Karolinska Institute, Stockholm, Sweden.
Kutty Selva NandakumarDepartment of Medical Biochemistry and Biophysics, Section for Medical Inflammation Research, Karolinska Institute, Stockholm, Sweden.
Bibo LiangDepartment of Medical Biochemistry and Biophysics, Section for Medical Inflammation Research, Karolinska Institute, Stockholm, Sweden.
Changrong GeDepartment of Medical Biochemistry and Biophysics, Section for Medical Inflammation Research, Karolinska Institute, Stockholm, Sweden.
Johan ViljanenDepartment of Chemistry-Biomedical Center, Section of Organic Chemistry, Uppsala University, Uppsala, Sweden.
Lei LiDepartment of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
Mirela BãlanDepartment of Medical Biochemistry and Biophysics, Section of Vascular Biology, Karolinska Institute, Stockholm, Sweden.
Lars KlareskogRheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
Andrei S ChaginDepartment of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
Inger GjertssonDepartment of Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, Sweden.
Jan KihlbergDepartment of Chemistry-Biomedical Center, Section of Organic Chemistry, Uppsala University, Uppsala, Sweden.
Ming ZhaoDepartment of Pathophysiology, Key Laboratory for Shock and Microcirculation Research of Guangdong, Southern Medical University, Guangzhou, China.
Rikard HolmdahlDepartment of Medical Biochemistry and Biophysics, Section for Medical Inflammation Research, Karolinska Institute, Stockholm, Sweden.
Karolinska Institutet · SESouthern Medical University · CNUppsala University · SEKarolinska University Hospital · SEUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Collagen XI (CXI) is a heterotrimeric molecule with triple helical structure in which the α3(XI) chain is identical to the α1(II) chain of collagen II (CII), but with extensive posttranslational modifications. CXI molecules are intermingled in the cartilage collagen fibers, which are mainly composed of CII. One of the alpha chains in CXI is shared with CII and contains the immunodominant T cell epitope, but it is unclear whether there are shared B cell epitopes as the antibodies tend to recognize the triple helical structures. Methods: Mice expressing the susceptible immune response gene Results: Immunization with CII or CXI leads to a strong T and B cell response, including a cross-reactive response to both collagen types. Immunization with CII leads to severe arthritis in mice, with a response toward CXI at the chronic stage, whereas CXI immunization induces very mild arthritis only. A series of monoclonal antibodies to CXI were isolated and of these, the L10D9 antibody bound to both CXI and CII equally strong, with a specific binding for the D3 epitope region of α3(XI) or α1(II) chain. The L10D9 antibody binds cartilage Conclusion: CXI is immunologically not exposed in healthy cartilage but contains T and B cell epitopes cross-reactive with CII, which could be activated in both mouse and human arthritis and could evoke an arthritogenic response.

Indexed as

AnimalsArthritisAutoantibodiesB-LymphocytesCartilageCells, CulturedCollagen Type IICollagen Type XIDisease Models, AnimalEpitopes, B-LymphocyteEpitopes, T-LymphocyteHumansImmunodominant EpitopesMaleMiceMice, Inbred DBAAutoantibodiesCollagen Type IICollagen Type XIEpitopes, B-LymphocyteEpitopes, T-LymphocyteImmunodominant EpitopesarthritisautoantibodyCIIcollagen XIcross-reactiverheumatoid arthritis

Identifiers

PMID29706949
PMCPMC5906551
OpenAlexW2892742638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.